Consultancy is offered on all aspects of non-clinical drug development, including drug discovery, preclinical development, regulatory affairs, intellectual property and marketing positioning relating to drug development.


Preclinical discovery and development

  • Target evaluation and validation
  • Pharmacological optimisation
  • Drug development plans
  • Target product profiles


Drug Abuse evaluation

  • Study design and management
  • Abuse liability report preparation
  • Meetings with regulatory authorities (FDA, DEA, EMA, and other global regulatory authorities)



  • Extensive experience of interactions with regulatory agencies including Japan


IP, development strategy

  • Evaluation of licensing opportunities
  • Due-diligence reviews
  • Scientific advisory board participation
  • Strategic reviews of discovery and development portfolios
  • Intellectual property evaluation

Contact us

For more details or information on how we can support your project please complete the contact form.